Skip to main content
IFNbeta lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS.
Practice parameter: neuroimaging of the neonate: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
Multiple risk factors in neonatal sinovenous thrombosis.
Deaths from stroke in US children, 1979 to 1998.
Molecular findings in symptomatic and pre-symptomatic Alexander disease patients.
Seizure-associated brain injury in term newborns with perinatal asphyxia.
Arterial dissection and stroke in children.
Magnetization transfer ratio in new MS lesions before and during therapy with IFNbeta-1a.
A phase I trial of solubilized DR2:MBP84-102 (AG284) in multiple sclerosis.
Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis.